EXTRAWELL PHAR(00858) released its interim results with a net loss attributable to shareholders of HK$460 million, a year-on-year change from profit to loss.

23:12 28/11/2025

Jingyou Pharmaceutical (00858) released its interim results for the six months ended September 30, 2025, with a revenue of 28.008 million Hong Kong dollars, a decrease of 9.04% year-on-year; shareholders' attributable loss of 460 million Hong Kong dollars, a year-on-year change from profit to loss; loss per share of 19.09 Hong Kong cents.

EXTRAWELL PHAR (00858) has reported its interim performance for the six months ending September 30, 2025, with a revenue of HK$280.8 million, a decrease of 9.04% year-on-year; shareholders' net loss was HK$460 million, a turnaround from profit to loss; loss per share was 19.09 HK cents.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.